Rovida Advisors Inc. Helius Medical Technologies, Inc. Transaction History

Rovida Advisors Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$3.07 - $5.55 $82,687 - $149,483	-26,934 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$5.12 - $14.5 $51,200 - $145,000	-10,000 Reduced 27.08%	26,934 $140,000
Q1 2021 May 14, 2021	BUY	$11.23 - $18.35 $414,768 - $677,738	36,934 New	36,934 $650,000

Ticker HSDT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 28,197,200
Market Cap $12.7M
Description
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gai...

Get notified when there are updates to the investment portfolio of Rovida Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Rovida Advisors Inc. with notifications on news.